Overview
- 15 inspections across 15 sites are on record.
- 63 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-08-06.
At a glance
Inspections
15
Sites
15
Observations
63
Career since
Apr 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| LGM Pharma Solutions, LLC. | 6 Aug 2025 | Human Drugs | View 483 → |
| ZebraSci, Inc. | 27 Jun 2025 | Human Drugs | |
| Infinity Labs, SD Inc. | 27 Mar 2025 | Human Drugs | |
| Noble Panacea Labs, Inc. | 8 Nov 2024 | Human Drugs | View 483 → |
| Orange Lab | 19 Jul 2024 | Human Drugs | On file |
Sites inspected
LGM Pharma Solutions, LLC.Rosenberg, United States1 insp.
ZebraSci, Inc.Temecula, United States1 insp.
Infinity Labs, SD Inc.San Diego, United States1 insp.
Noble Panacea Labs, Inc.Irvine, United States1 insp.
Orange LabAnaheim, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joey V Quitania2 shared
Rowena S Nguyen2 shared
Crystal Monroy2 shared
Nicholas L Hunt2 shared
Roger F Zabinski2 shared
Nadeem I Chaudhry1 shared
Homero W Aguilar1 shared
Lillian S Wu1 shared
Michael T Cyrus1 shared
Walden H Lee1 shared
Full investigator report
Get the verbatim findings behind Rachel C Stanton's 63 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site